Schamroth Michael 4
4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed Jun 4, 2018
Insider Transaction Report
Form 4
Schamroth Michael
Director
Transactions
- Conversion
Common Stock, $0.001 par value
2018-06-04$13.60/sh+15,000$204,000→ 84,000 total - Conversion
Stock Option (Right to Buy)
2018-06-04−15,000→ 0 totalExercise: $13.60Exp: 2018-06-09→ Cmn Stk $.001pv (15,000 underlying)
Footnotes (1)
- [F1]The option vests monthly with respect to 1/12 of the total number of shares until all shares underlying the option have vested.